Abbott Laboratories buy Daiwa Capital Markets
Start price
31.01.26
/
50%
€92.30
Target price
31.01.27
€95.29
Performance (%)
2.15%
Price
18:39
€94.28
Summary
This prediction is currently active. With a performance of 2.15%, the BUY prediction by Daiwa_Capital_Market for Abbott Laboratories is trending in the right direction. This prediction currently runs until 31.01.27. The prediction end date can be changed by Daiwa_Capital_Market at any time. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 3.256% | 3.256% |
| iShares Core DAX® | 2.992% | 3.220% |
| iShares Nasdaq 100 | -1.584% | -3.172% |
| iShares Nikkei 225® | -2.254% | -9.924% |
| iShares S&P 500 | -0.009% | 1.641% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at Daiwa Capital Markets from $136.00 to $113.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Daiwa_Capital_Market for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.72
21.10.25
21.10.25
€116.80
21.10.26
21.10.26
-14.31%
18:39
18:39
